{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:42:01Z","timestamp":1780634521062,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,27]]},"DOI":"10.7759\/cureus.42576","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T23:42:00Z","timestamp":1690501320000},"source":"Crossref","is-referenced-by-count":2,"title":["Two Cases of Inadequate Response to Remimazolam"],"prefix":"10.7759","author":[{"given":"Atsuhiro","family":"Kitaura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroatsu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Tsukimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-020-02755-1","article-title":"Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!","volume":"34","author":"Masui K","year":"2020","unstructured":"Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!. J Anesth. 2020, 34:479-82. 10.1007\/s00540-020-02755-1","journal-title":"J Anesth"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik LJ","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012, 115:274-83. 10.1213\/ANE.0b013e31823f0c28","journal-title":"Anesth Analg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-020-02776-w","article-title":"Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial","volume":"34","author":"Doi M","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020, 34:491-501. 10.1007\/s00540-020-02776-w","journal-title":"J Anesth"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823acb95","article-title":"Remimazolam: new beginnings or just a me-too?","volume":"115","author":"Sneyd JR","year":"2012","unstructured":"Sneyd JR. Remimazolam: new beginnings or just a me-too?. Anesth Analg. 2012, 115:217-9. 10.1213\/ANE.0b013e31823acb95","journal-title":"Anesth Analg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173886","article-title":"A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam","volume":"896","author":"Io T","year":"2021","unstructured":"Io T, Saunders R, Pesic M, Petersen KU, Stoehr T. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam. Eur J Pharmacol. 2021, 896:173886. 10.1016\/j.ejphar.2021.173886","journal-title":"Eur J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2199\/jjsca.34.860","article-title":"Remimazolam (Article in Japanese)","volume":"34","author":"Doi M","year":"2014","unstructured":"Doi M. Remimazolam (Article in Japanese). J Jpn Soc Clin Anesth. 2014, 34:860-6. 10.2199\/jjsca.34.860","journal-title":"J Jpn Soc Clin Anesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial","volume":"34","author":"Doi M","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020, 34:543-53. 10.1007\/s00540-020-02788-6","journal-title":"J Anesth"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-022-03079-y","article-title":"A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice","volume":"36","author":"Masui K","year":"2022","unstructured":"Masui K, St\u00f6hr T, Pesic M, Tonai T. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice. J Anesth. 2022, 36:493-505. 10.1007\/s00540-022-03079-y","journal-title":"J Anesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199704000-00014","article-title":"Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers","volume":"86","author":"Glass PS","year":"1997","unstructured":"Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology. 1997, 86:836-47. 10.1097\/00000542-199704000-00014","journal-title":"Anesthesiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200111000-00019","article-title":"Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol","volume":"95","author":"Ibrahim AE","year":"2001","unstructured":"Ibrahim AE, Taraday JK, Kharasch ED. Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol. Anesthesiology. 2001, 95:1151-9. 10.1097\/00000542-200111000-00019","journal-title":"Anesthesiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.12.030","article-title":"Activation-induced regulation of GABAA receptors: is there a link with the molecular basis of benzodiazepine tolerance?","volume":"109","author":"Gravielle MC","year":"2016","unstructured":"Gravielle MC. Activation-induced regulation of GABAA receptors: is there a link with the molecular basis of benzodiazepine tolerance?. Pharmacol Res. 2016, 109:92-100. 10.1016\/j.phrs.2015.12.030","journal-title":"Pharmacol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2008.00043.x","article-title":"The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties","volume":"14","author":"Kotani Y","year":"2008","unstructured":"Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008, 14:95-106. 10.1111\/j.1527-3458.2008.00043.x","journal-title":"CNS Neurosci Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001460","article-title":"Remimazolam tolerance in long-term benzodiazepine users: a case report of 2 cases","volume":"15","author":"Yoshikawa H","year":"2021","unstructured":"Yoshikawa H, Hosokawa M, Kashima Y, Oki S, Masui K. Remimazolam tolerance in long-term benzodiazepine users: a case report of 2 cases. A A Pract. 2021, 15:e01460. 10.1213\/XAA.0000000000001460","journal-title":"A A Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s40981-021-00485-1","article-title":"Three cases of difficulty in achieving definitive loss of consciousness with remimazolam","volume":"8","author":"Miyanishi M","year":"2022","unstructured":"Miyanishi M, Yaguramaki T, Maehara Y, Nagata O. Three cases of difficulty in achieving definitive loss of consciousness with remimazolam. JA Clin Rep. 2022, 8:4. 10.1186\/s40981-021-00485-1","journal-title":"JA Clin Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-022-03139-3","article-title":"Tolerance to remimazolam at a high effect-site concentration","volume":"37","author":"Kida K","year":"2023","unstructured":"Kida K, Taguchi M, Uchiyama K, Fujioka S, Tsubokawa T. Tolerance to remimazolam at a high effect-site concentration. J Anesth. 2023, 37:168-9. 10.1007\/s00540-022-03139-3","journal-title":"J Anesth"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200108000-00007","article-title":"A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model","volume":"95","author":"Barr J","year":"2001","unstructured":"Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology. 2001, 95:286-98. 10.1097\/00000542-200108000-00007","journal-title":"Anesthesiology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/172835-two-cases-of-inadequate-response-to-remimazolam","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:41Z","timestamp":1707508901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/172835-two-cases-of-inadequate-response-to-remimazolam"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.42576","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}